Treatment patterns in multiple myeloma: Real-world experience of the triple-class exposed (TCE) patient.

被引：0
|
作者：
Shah, Nina
Crivera, Concetta
Mehra, Maneesha
Mohammadi, Iman
Kilgore, Karl M.
Wong, Anny C.
Jagannath, Sundar
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Janssen Sci Affairs LLC, Raritan, NJ USA
[3] Janssen Global Serv, Raritan, NJ USA
[4] Avalere Hlth LLC, Washington, DC USA
[5] Avalere Hlth LLC, Bowie, MD USA
[6] Mt Sinai Med Ctr, New York, NY 10029 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20543
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Real-world treatment patterns and clinical outcomes among patients with triple-class exposed (TCE) multiple myeloma (MM)
    Fonseca, Rafael
    Harper, Jennifer
    Le, Hoa
    Fu, Alex
    Patel, Saurabh
    Wu, Bingcao
    Zhang, Xinke
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S177 - S178
  • [2] Real-world treatment patterns and outcomes of triple-class treated patients with multiple myeloma in the United States
    Varughese, Prateesh
    Smith, Robert
    Xue, Mei
    Dorrow, Natalie
    Hogea, Cosmina
    Maiese, Eric. M.
    Buckingham, Trudy
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2023, 16 (01) : 65 - 74
  • [3] Comparative effectiveness of teclistamab versus real-world treatments for patients with triple-class exposed (TCE), relapsed/refractory multiple myeloma (RRMM).
    Krishnan, Amrita Y.
    Nooka, Ajay K.
    Chari, Ajai
    Garfall, Alfred L.
    Martin, Thomas G.
    Nair, Sandhya
    Lin, Xiwu
    Qi, Keqin
    Londhe, Anil
    Pei, Lixia
    Eric, Ammann
    Kobos, Rachel
    Smit, Jennifer
    Parekh, Trilok V.
    Slavcev, Mary
    Usmani, Saad Zafar
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [4] Real-world clinical outcomes and treatment patterns among patients with triple-class exposed multiple myeloma: an analysis using the Connect® multiple myeloma disease registry
    Lee, Hans
    Ailawadhi, Sikander
    Dhanda, Devender
    Patwardhan, Pallavi
    Yu, Edward
    Liu, Liang
    Rifkin, Robert
    Terebelo, Howard
    Abonour, Rafat
    Narang, Mohit
    Gasparetto, Cristina
    Toomey, Kathleen
    Hardin, James
    Durie, Brian
    Jagannath, Sundar
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S193 - S194
  • [5] Real-world treatment patterns, healthcare use and costs in triple-class exposed relapsed and refractory multiple myeloma patients in the United States
    Madduri, Deepu
    Hagiwara, May
    Parikh, Kejal
    Pelletier, Corey
    Delea, Thomas E.
    Kee, Arianna
    Chari, Ajai
    [J]. FUTURE ONCOLOGY, 2021, 17 (05) : 503 - 515
  • [6] Real-world treatment patterns and clinical outcomes in patients with triple-class exposed relapsed or refractory multiple myeloma in United States clinical practice
    Chari, Ajai
    Nair, Sandhya
    Lin, Xiwu
    Marshall, Alexander
    Slavcev, Mary
    Kumar, Shaji
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S165 - S166
  • [7] Real-World Treatment Patterns and Clinical Outcomes Among Triple-Class Exposed and B- Cell Maturation Antigen (BCMA) Exposed Multiple Myeloma Patients
    Mian, Hira
    Harper, Jennifer S.
    Le, Hoa H.
    Fu, Alex Z.
    Patel, Saurabh N.
    Zhang, Xinke
    Fonseca, Rafael
    [J]. BLOOD, 2023, 142
  • [8] Teclistamab versus real-world physician's choice of therapy in triple-class exposed relapsed/refractory multiple myeloma
    Krishnan, Amrita
    Nooka, Ajay K.
    Chari, Ajai
    Garfall, Alfred L.
    Martin, Thomas G.
    Nair, Sandhya
    Lin, Xiwu
    Qi, Keqin
    Londhe, Anil
    Pei, Lixia
    Ammann, Eric
    Kobos, Rachel
    Smit, Jennifer
    Parekh, Trilok
    Marshall, Alexander
    Slavcev, Mary
    Usmani, Saad Z.
    [J]. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2023, 12 (06)
  • [9] Real-World Clinical Outcomes Among Triple-Class Exposed Multiple Myeloma Patients and Subgroups in the US Oncology Network
    Rifkin, Robert M.
    Harper, Jennifer S.
    Le, Hoa H.
    Fu, Alex Z.
    Patel, Saurabh N.
    Zhang, Xinke
    Zackon, Ira L.
    [J]. BLOOD, 2023, 142
  • [10] From triple-class exposed (TCE) to penta-exposed and triple-class refractory (PE-TCR): Real-world outcomes across a spectrum of advanced relapsed or refractory multiple myeloma (RRMM) patients (Pts) in the United States.
    Delea, Thomas E.
    Song, Xue
    Ge, Wenzhen
    Chi, Lei
    Eichten, Caitlin
    Moynahan, Aaron
    Weycker, Derek
    Ma, Qiufei
    Kroog, Glenn Scott
    Rodriguez-Lorenc, Karen
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345